Clinical Trial Update: A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT [Phase 4]

View source ↗

Summary

A Phase IV randomized trial evaluated a single high-dose oral vitamin D3 in pediatric patients undergoing stem cell transplantation; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stem Cell Transplant Complications
• Vitamin Deficiency

Snippet

Sponsor: Phoenix Children's Hospital | Conditions: Vitamin D Deficiency, Stem Cell Transplant Complications | Phase 4 | Status: COMPLETED